Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAAS Blockade Comparison in Non-diabetic CKD
NCT01541267Phase 4Completed
- Sponsor
- Medical University of Gdańsk
- Start
- Dec 2009
- Primary completion
- May 2011
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of aliskiren, eplerenone, telmisartan in chronic kidney disease (CKD), proteinuria, sponsored by Medical University of Gdańsk. Started Dec 2009; status: completed.
02
Drugs
aliskireneplerenonetelmisartan
03
Conditions
chronic kidney disease (CKD)proteinuria
Beyond the preview
Go deeper on NCT01541267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01541267.